Broad-Based Black Economic Empowerment Act (B-BBEE Act)
Act 53 of 2003
Provides the empowerment-compliance context often used in public-sector supplier evaluation.
Relevant because this is a South African public-sector procurement opportunity.
Documents available on tender detail page
Tender Type
Request for Bid(Open-Tender)
Delivery Location
1112 Voortrekker Road - Pretoria Townlands 351-JR - Pretoria - 0001
Organization Type
GOVERNMENT
Published
05 Jun 2026
OCDS Reference
ocds-9t57fa-158259
This tender invites bids for the supply and delivery of diagnostic agents and contrast media to the south african department of health over a three-year period (01 july 2027 to 30 june 2030). IT is open to suppliers who can meet strict compliance, technical, and financial requirements, including b-bbee and tax obligations.
Contact Information
Source: 6.HP05-2027DI PBD4.1 Contact Details_Bidder 5 June 2026.xlsx (unknown)Bidder must provide the following contact details in PBD4.1:
The special requirements and conditions of contracts is in the final bid pack
Categories
Request for Bid(Open-Tender)
1112 Voortrekker Road - Pretoria Townlands 351-JR - Pretoria - 0001
These references help suppliers understand the public-procurement framework around this opportunity. They are generated from the tender category, issuing organisation type and procurement context.
9. HP05-2027DI_Final BidResp_5 June 2026.xlsx
The tender HP05-2027DI is for the supply and delivery of diagnostic agents and contrast media to the Gauteng Department of Health for a 3-year period (01 July 2027 to 30 June 2030). It includes 18 items such as barium sulfate suspensions, fluorescein sodium strips, gadolinium-based contrast agents, iohexol injections, tuberculin PPD, and urine test strips. Bidders must provide pricing, compliance details, and logistical information for each item.
Date & Time
Monday, 03 August 2026 - 11:00
Venue
https://teams.microsoft.com/meet/388217308025388?p=WfBeSih4py014XrsDF
05 Jun
2026
Tender Published
Tender was published
03 Aug
2026
Closing Date
Tender closing date
Learn how to submit a winning bid with these related articles
A comprehensive guide to securing medical equipment maintenance tenders in South African public hospitals. Learn about SLA management, OEM certifications, and clinical engineering requirements.
As a General supplier in Gauteng, it is essential to understand the schedule classification of medical devices and its impact on tender eligibility. In 2026, the South African government continues to prioritize healthcare, and medical device procurement plays a critical role in this endeavor. The current regulatory environment demands strict compliance with various laws and regulations, making it crucial for suppliers to ensure they meet the necessary requirements. In this article, we will provide a comprehensive guide on the schedule classification of medical devices and its implications for General suppliers in Gauteng.
Supplying medicines and medical devices to the state is highly regulated. Understand SAHPRA licensure, strict quality controls, and the logistical demands of healthcare procurement.
Efficiency behind the scenes: How professional medical management and specialized procurement are transforming South African hospitals for better clinical outcomes.
💡 Want more tendering tips and strategies?
Explore Our BlogMedian Estimate
R 84 551
Range
Based on 4 comparable awarded tenders. Companies with similar profiles typically bid near the median.
* Estimates are based on historical data and do not guarantee actual award values.
Submission Guidelines
Source: 6.HP05-2027DI PBD4.1 Contact Details_Bidder 5 June 2026.xlsx (unknown)Returnable Documents: Submit all required forms as specified in the tender document. Ensure all sections of PBD4.1 (Bidder Contact Details) are completed accurately, including legal name, CSD number, vendor number, and contact details for contract enquiries, orders, and tender management.
Evaluation Criteria
Source: 6.HP05-2027DI PBD4.1 Contact Details_Bidder 5 June 2026.xlsx (unknown)Registration
Bidder must be registered on the Central Supplier Database (CSD) with a valid CSD number.
Vendor Status
Must have a vendor number (implied requirement for existing suppliers).
Legal Status
Registered legal entity (name must match CSD records).
Contactability
Provide verifiable contact details for contract, orders, and tender management.
Important Dates
Source: 1. HP05-2027DI__Invitation to bid_ notice_for NDOH website_5 June 2026.pdf (TENDER)Closing date and time: 3 August 2026 at 11:00 am. Non-compulsory online briefing session: 19 June 2026 at 10:00 via MS Teams. Join using the link: https://teams.microsoft.com/meet/388217308025388?p=WfBeSih4py014XrsDF. Bid documents published on the website: 5 June 2026.
Contact Information
Source: 1. HP05-2027DI__Invitation to bid_ notice_for NDOH website_5 June 2026.pdf (TENDER)For all bid-related enquiries, email: [email protected]. Office hours: 07h30 - 15h30. Submission address: DR AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, PRETORIA, 0143.
Submission Guidelines
Source: 1. HP05-2027DI__Invitation to bid_ notice_for NDOH website_5 June 2026.pdf (TENDER)Submit bids in person to: DR AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, PRETORIA, 0143. Bids must be delivered by the closing date and time. Bids are obtainable from the Department of Health website (www.health.gov.za) under the "TENDERS" tab, then "PHARMACEUTICAL TENDERS". Prospective bidders must submit all enquiries via email to [email protected] timeously to allow responses before the tender closes. Office hours: 07h30 - 15h30.
Evaluation Criteria
Source: 1. HP05-2027DI__Invitation to bid_ notice_for NDOH website_5 June 2026.pdf (TENDER)General
Open to all bidders who meet the administrative, technical, legal, and B-BBEE requirements.
Registration
Bidders must be registered and capable of supplying diagnostic agents and contrast media as per the tender specifications.
Timeliness
Bids must be submitted by the closing date (03 August 2026, 11:00 AM UTC). Late submissions will not be considered.
Technical Specifications
Source: 1. HP05-2027DI__Invitation to bid_ notice_for NDOH website_5 June 2026.pdf (TENDER)Supply and delivery of diagnostic agents and contrast media to the Department of Health for the period 01 July 2027 to 30 June 2030.
Compliance Requirements
Source: 1. HP05-2027DI__Invitation to bid_ notice_for NDOH website_5 June 2026.pdf (TENDER)Compliance with mandatory administrative bid requirements (Phase I). Compliance with product, technical, and legal mandatory requirements (Phase II). Compliance with B-BBEE requirements (Phase III). Bidders must adhere to the Special Requirements and Conditions of Contract (SRCC) as per Section 9 of the bid document.
Section
Source: 1. HP05-2027DI__Invitation to bid_ notice_for NDOH website_5 June 2026.pdfEvaluation will be conducted in four (04) phases: Phase I: Compliance with mandatory administrative bid requirements. Phase II: Compliance with product, technical, and legal mandatory requirements. Phase III: Evaluation of compliance with B-BBEE requirements. Phase IV: Recommendation and award based on the above phases.
Important Dates
Source: 2. HP05-2027DI_Final Bid Pack-5 June 2026.pdf (TENDER)Closing date: 03 August 2026 at 11:00. Non-compulsory online briefing session: 19 June 2026 at 10:00 via MS Teams.
Contact Information
Source: 2. HP05-2027DI_Final Bid Pack-5 June 2026.pdf (TENDER)Queries: Email [email protected]. Submission address: Dr AB Xuma Building, 1112 Voortrekker Road, Block A, Pretoria Townlands 351-JR, Pretoria, 0187. Pharmaceutical Tender Box in the reception area. For NIP Programme queries: Contact Ms R Muthan at (012) 394 1288, Mobile (066) 301 2051, or email [email protected].
Submission Guidelines
Source: 2. HP05-2027DI_Final Bid Pack-5 June 2026.pdf (TENDER)Submit bids in the official forms provided (do not re-type). Deliver bids by the closing date and time (03 August 2026, 11:00) to: The Director-General: Health, Directorate: Affordable Medicines, Dr AB Xuma Building, 1112 Voortrekker Road, Block A, Pretoria Townlands 351-JR, Pretoria, 0187. Deposit bids in the Pharmaceutical Tender Box in the reception area. Late bids will not be accepted. Ensure bids are addressed and delivered to the correct location. Bids must include all required documents as per the Bid Document Checklist (Paragraph 3) and Bid Documents (Paragraph 4.1.1 to 4.1.7). Consortiums, joint ventures, and partnerships must comply with Paragraph 4.3. Submission requirements are detailed in Paragraphs 9 and 10.
Evaluation Criteria
Source: 2. HP05-2027DI_Final Bid Pack-5 June 2026.pdf (TENDER)General
Tax
B-BBEE
Industrial Participation
Financial Requirements
Source: 2. HP05-2027DI_Final Bid Pack-5 June 2026.pdf (TENDER)Bid validity period: 180 days. Successful bidders with contracts exceeding R10 million must comply with the National Industrial Participation (NIP) Programme. This includes submitting a performance guarantee to the DTI, a business concept for approval, detailed business plans, and bi-annual progress reports. NIP obligations apply if imported content meets or exceeds US$10 million (or equivalent) under specific conditions. For contracts with imported content, submit details to the DTI within 5 working days of award. Pricing must be submitted as per the official bid forms.
Compliance Requirements
Source: 2. HP05-2027DI_Final Bid Pack-5 June 2026.pdf (TENDER)Tax Compliance: Submit a Tax Compliance Status (TCS) PIN (via SARS e-filing) or a CSD registration number. Each party in a consortium/joint venture must submit separate TCS/CSD documentation. VAT registration details are required. B-BBEE: Submit a valid SANAS-accredited B-BBEE certificate or sworn affidavit (for EMEs/QSEs). Bidders must not be listed on the Register for Tender Defaulters or the List of Restricted Suppliers. Bidders must declare if they or their directors are employed by the state. Foreign suppliers must complete the Questionnaire for Bidding Foreign Suppliers. Bidders must confirm financial solvency and absence of business rescue/liquidation via PBD11.
Contractual Terms
Source: 2. HP05-2027DI_Final Bid Pack-5 June 2026.pdfContract duration: 01 July 2027 to 30 June 2030. Successful bidders must sign a written contract (SBD7). Contracts exceeding R10 million must comply with the National Industrial Participation (NIP) Programme, including submitting a performance guarantee, business concept, and detailed plans to the DTI. Non-compliance with financial solvency declarations or false information may result in disqualification, contract termination, reporting to National Treasury, or legal action. Bidders must notify the Department within 5 working days of any material financial changes during the bid validity or contract term.
Section
Source: 2. HP05-2027DI_Final Bid Pack-5 June 2026.pdfEvaluation is based on the 90/10 Preferential Procurement Regulations, 2022. 90 points are allocated for price (lowest price scores highest). 10 points are allocated for B-BBEE Status Level of Contributor, with higher levels receiving more points. Points are awarded as follows: Level 1 (10), Level 2 (9), Level 3 (8), Level 4 (6), Level 5 (5), Level 6 (4), Level 7 (3), Level 8 (2), Non-compliant (0). Valid B-BBEE certificates or sworn affidavits (for EMEs/QSEs) are required to claim points.
Submission Guidelines
Source: 7. HP05-2027DI_PBD9.1-Directors-Categorisation-_Single Bid_Entity_5 June 2026.xlsx (unknown)Returnable Documents: Bidders must mark with an X in the relevant cell to indicate the type of single bidding enterprise (e.g., Close Corporation, Company, Incorporated Joint Venture, Listed Company).
Evaluation Criteria
Source: 7. HP05-2027DI_PBD9.1-Directors-Categorisation-_Single Bid_Entity_5 June 2026.xlsx (unknown)Eligible bidders must be legally registered entities (e.g., Close Corporation, Company, etc.) with valid director details. Foreign bidders must provide passport numbers. Conflicts of interest (e.g., ownership in related bidding enterprises) must be declared.
Description
Source: 8. HP05-2027DI_PBD9.2-Directors-Categorisation-_JV_Consort_P-Ship_5 June 2026.xlsxBidders must categorise their multi-entity bidding enterprise as one of the following: Partnership, Joint Venture Unincorporated, Consortium, or Listed Company. Details of all directors for each entity must be provided.
Submission Guidelines
Source: 8. HP05-2027DI_PBD9.2-Directors-Categorisation-_JV_Consort_P-Ship_5 June 2026.xlsx (unknown)Returnable Documents: Submit completed PBD9.2 form with details of all directors for each entity in the bidding enterprise.
Evaluation Criteria
Source: 8. HP05-2027DI_PBD9.2-Directors-Categorisation-_JV_Consort_P-Ship_5 June 2026.xlsx (unknown)General
Directors
Enterprise Type
Must fall under one of the specified categories: Partnership, Joint Venture Unincorporated, Consortium, or Listed Company
Technical Specifications
Source: 8. HP05-2027DI_PBD9.2-Directors-Categorisation-_JV_Consort_P-Ship_5 June 2026.xlsx (unknown)Provide full details of all directors for each entity in the bidding enterprise, including: full names, surname, entity affiliation (A, B, or C), nationality, ID or passport number (for foreigners), director appointment status (Y/N), executive/non-executive role, and any other directorships or ownership in other enterprises.
Compliance Requirements
Source: 8. HP05-2027DI_PBD9.2-Directors-Categorisation-_JV_Consort_P-Ship_5 June 2026.xlsx (unknown)CSD registration (MAAA number) required for each entity in the bidding enterprise. Enterprise categorisation must be specified (Partnership, Joint Venture Unincorporated, Consortium, or Listed Company).
Description
Source: 9. HP05-2027DI_Final BidResp_5 June 2026.xlsxSupply and delivery of diagnostic agents and contrast media to the Department of Health for the period 01 July 2027 to 30 June 2030. Items include contrast media (e.g., barium sulfate, iohexol, gadobutrol), diagnostic strips (e.g., fluorescein, LAM antigen, urine test strips), and tuberculin PPD test kits. All items must meet specified volumes, concentrations, and packaging requirements.
Submission Guidelines
Source: 9. HP05-2027DI_Final BidResp_5 June 2026.xlsx (unknown)Submit the following returnable documents: Bid response form with all required fields completed, including item specifications, pricing, product registration details, and manufacturer/distributor information. Ensure all prices are in ZAR with two decimal places and do not exceed the SEP (current listing). Include conformance declarations, barcode details, and API source information where applicable.
Evaluation Criteria
Source: 9. HP05-2027DI_Final BidResp_5 June 2026.xlsx (unknown)Legal Status
Bidder must be a registered legal entity with a valid Central Supplier Database (CSD) number.
Compliance
Technical Capacity
Financial Capacity
Pricing must be competitive and within SEP limits.
Technical Specifications
Source: 9. HP05-2027DI_Final BidResp_5 June 2026.xlsx (unknown)Supply and deliver diagnostic agents and contrast media as per the following specifications: Barium sulfate 4.6% m/m suspension for CT scan examinations (225ml), Barium sulfate 96% powder for suspension for rectal use (prefilled enema kit, 397g), Barium sulfate 98% m/m powder for oral suspension (340g), Fluorescein sodium impregnated strips (sterile, 1mg, 100's), Fluorescein 100mg/ml injection (5ml), Gadobutrol 604.72mg/ml injection, Gadopentetic Acid 469.01mg/ml injection (20ml), LAM antigen urine test strips (25's with pipettes), Meglumine amidotrizoate/sodium amidotrizoate solutions (various concentrations and volumes), Iohexol injections (300mg and 350mg iodine/ml, 50ml and 100ml), Tuberculin PPD liquid test (2tu/0.1ml, 1.5ml vial kit), and urine test strips for 10 parameters (100 strips per container, long handle, ascorbic acid-resistant, results in ≤3 minutes).
Financial Requirements
Source: 9. HP05-2027DI_Final BidResp_5 June 2026.xlsx (unknown)Pricing must be provided in ZAR with two decimal places. Delivered price per unit and per shipper pack must not exceed the SEP (current listing). Include breakdown of delivered price attributable to API, formulation, packaging, logistics, and gross margin. Specify currency if not ZAR.
Compliance Requirements
Source: 9. HP05-2027DI_Final BidResp_5 June 2026.xlsx (unknown)Bidders must provide: Registered legal name, Central Supplier Database (CSD) number, product registration numbers, license to manufacture medicines (number and expiry date), and NAPPI codes. All products must conform to specifications (declare Y/N and detail deviations if any). Lead-time must not exceed 14 calendar days (or 75 days for initial delivery). Minimum order quantities and batch sizes must be specified. Local content (API, raw materials, formulation, packaging) must be declared with percentages.
Important Dates
Source: 4. HP05-2027DI_Annexure B_ Invoice requirements_5 June 2026.pdf (unknown)Closing date for submissions: 03 August 2026 at 11:00 SAST.
Contact Information
Source: 4. HP05-2027DI_Annexure B_ Invoice requirements_5 June 2026.pdf (unknown)Supplier must provide:
Note: No specific government contacts are provided in the document.
Submission Guidelines
Source: 4. HP05-2027DI_Annexure B_ Invoice requirements_5 June 2026.pdf (unknown)Returnable Documents: All invoices must include the following as per Annexure B:
Returnable Documents
Source: 4. HP05-2027DI_Annexure B_ Invoice requirements_5 June 2026.pdf (unknown)All invoices must include the following minimum data as per Annexure B:
Evaluation Criteria
Source: 4. HP05-2027DI_Annexure B_ Invoice requirements_5 June 2026.pdf (unknown)General
Technical
Financial
Technical Specifications
Source: 4. HP05-2027DI_Annexure B_ Invoice requirements_5 June 2026.pdf (unknown)Supply and delivery of diagnostic agents and contrast media must comply with:
Financial Requirements
Source: 4. HP05-2027DI_Annexure B_ Invoice requirements_5 June 2026.pdf (unknown)Invoicing requirements:
Compliance Requirements
Source: 4. HP05-2027DI_Annexure B_ Invoice requirements_5 June 2026.pdf (unknown)Mandatory compliance:
Section
Source: 4. HP05-2027DI_Annexure B_ Invoice requirements_5 June 2026.pdf (unknown)Supplier must provide contact details for:
Note: No government-side contacts are specified in the document.
Description
Source: 3. HP05-2027DI_Annexure A_Final_5 June 2026.xlsxThe tender requires the supply and delivery of diagnostic agents and contrast media to the Department of Health. Bidders must ensure all products meet regulatory standards, including valid SAHPRA-approved Medicine Registration Certificates (MRC) and compliance with Good Manufacturing Practice (GMP).
Submission Guidelines
Source: 3. HP05-2027DI_Annexure A_Final_5 June 2026.xlsx (unknown)Submit all bid documents in the exact order listed. Mandatory documents must be included; if a document is not applicable, mark it as 'N/A' with justification. Non-submission of mandatory documents will disqualify the bid. Required mandatory documents include: Covering Letter, PBD3 (Bid Signature Authorisation), SBD1 (Invitation to bid), CSD Registration report, SARS Tax Clearance Pin, CIPC registration certificate, SBD4 (Declaration of interest), SBD6.1 (Preference Points Claimed), Valid B-BBEE Certificate (SANAS accredited) or Sworn Affidavit for EME/QSE, PBD11 (Declaration of Financial Solvency), PBD5 (GMP Compliance Declaration), SBD5 (National Industrial Participation Programme), Valid licences to manufacture/import (LICMI, LICM, LICCM, LICMD), MRC (Medicine Registration Certificates) with annexures, PBD8 (SRCC and GCC Compliance Declaration), SRCC and GCC copies (initial every page), and Signed Excel Bid Response (Pricing Schedule). Additional administrative documents include Bid/File Index, PBD4.1 (Contact Details), CIPC notice of change in Directors, Proof of company changes, PBD9.1/9.2 (Entity Directors), Identification documents of Directors, PBD1 (Third Party Authorisation), PBD1.1/1.2 (Third Party Product List and Undertaking), Package Inserts, Proof of sample submission, Bidder’s item list, and USB with digital copies. USB files must be saved with index admin code abbreviations. Unsigned Pricing Schedule will result in disqualification.
Evaluation Criteria
Source: 3. HP05-2027DI_Annexure A_Final_5 June 2026.xlsx (unknown)Legal
Technical
Financial
Operational
Technical Specifications
Source: 3. HP05-2027DI_Annexure A_Final_5 June 2026.xlsx (unknown)Bidders must ensure all products comply with regulatory requirements, including valid Medicine Registration Certificates (MRC) issued by SAHPRA, with annexures. Products must have approved Package Inserts (PI) with QR codes for professional information. Proof of sample submission may be required. Bidders must also provide a list of products offered (Bidder’s item list).
Compliance Requirements
Source: 3. HP05-2027DI_Annexure A_Final_5 June 2026.xlsx (unknown)Mandatory compliance documents: Valid CSD Registration report, SARS Tax Clearance Pin, CIPC registration certificate, Valid B-BBEE Certificate (SANAS accredited) or Sworn Affidavit for EME/QSE, Declaration of Financial Solvency and Business Rescue Status (PBD11), GMP Compliance Declaration (PBD5), National Industrial Participation Programme (SBD5), Valid licences to manufacture/import (LICMI, LICM, LICCM, LICMD) with certified copies and annexures, MRC and MRC Annexures (SAHPRA), Variation Summary (VARSUM) for MRC changes, SRCC and GCC Compliance Declaration (PBD8).
Evaluation Criteria
Source: 5. HP05-2027DI-Annexure_C_Guidance_QSE_EME_5 June 2026.pdf (unknown)Turnover
EME
Annual turnover < R10,000,000
QSE
Annual turnover between R10,000,000 and R50,000,000
Large Enterprise
Annual turnover > R50,000,000 (requires SANAS B-BBEE certificate)
Bbbee Compliance
Must have valid B-BBEE status (Level 1–8 for QSEs/EMEs; certified for large enterprises).
Empowering Supplier
QSEs must indicate basis for empowering supplier status.
Compliance Requirements
Source: 5. HP05-2027DI-Annexure_C_Guidance_QSE_EME_5 June 2026.pdf (unknown)B-BBEE Compliance: Bidders must classify as either a Qualifying Small Enterprise (QSE) or Exempted Micro Enterprise (EME) to submit a sworn affidavit. QSE: Annual turnover between R10,000,000 and R50,000,000. EME: Annual turnover less than R10,000,000. Bidders with turnover exceeding R50,000,000 must submit a valid SANAS-accredited B-BBEE certificate and cannot use the EME/QSE affidavit. Sworn Affidavit Requirements: 1. Deponent’s full name and ID number as per identity document. 2. Designation (director, owner, or member) must be clearly indicated and underlined/circled. 3. Enterprise name (as per CIPC registration) and business address. 4. Percentage of black ownership, black female ownership, and designated group ownership. 5. Total revenue for the year under review, specifying if based on audited financial statements or management accounts. 6. Financial year-end as per enterprise registration documents. 7. B-BBEE Status Level of Contributor (only one level permitted). 8. Empowering supplier status (QSEs must specify the basis). 9. Deponent and Commissioner of Oaths’ signature dates must match. 10. Commissioner of Oaths cannot be an employee or ex-officio of the enterprise.
Section
Source: 5. HP05-2027DI-Annexure_C_Guidance_QSE_EME_5 June 2026.pdfPreference points for specific goals are allocated under the Preferential Procurement Regulations, 2022. Incorrectly completed QSE/EME sworn affidavits are deemed invalid, and no preference points will be awarded.
Tenders in this industry often require registration with these bodies.
Recommended Certifications
Having these can improve your winning chances: SANC Registration, SAPC Registration, ISO 15189 (Medical Laboratory Quality)
These rules commonly apply to South African public-sector procurement.
Act 53 of 2003
Provides the empowerment-compliance context often used in public-sector supplier evaluation.
Relevant because this is a South African public-sector procurement opportunity.
Act 108 of 1996 (s217)
Sets the constitutional standard for fair, equitable, transparent, competitive and cost-effective public procurement.
Relevant because this is a South African public-sector procurement opportunity.
Act 5 of 2000
Covers preferential procurement and preference-point systems used in public tenders.
Relevant because this is a South African public-sector procurement opportunity.
Act 12 of 2004
Supports anti-corruption controls and supplier integrity in procurement processes.
Relevant because this is a South African public-sector procurement opportunity.
Act 28 of 2024
Provides the national framework for public procurement across government.
Relevant because this is a South African public-sector procurement opportunity.
Act 2 of 2000
Supports access to tender records, award decisions and public-sector procurement information.
Relevant because this is a South African public-sector procurement opportunity.
Act 3 of 2000
Supports lawful, reasonable and procedurally fair administrative tender decisions.
Relevant because this is a South African public-sector procurement opportunity.
These rules are linked to the work category, industry, or regulated service area.
Act 61 of 2003
Relevant to healthcare services, public health facilities and health-sector procurement.
Relevant because this tender appears to involve health services, public health facilities, clinical services, or medical procurement.
Act 85 of 1993
This is general procurement context, not legal advice. Always verify requirements in the official tender documents and issuing authority notices.
3. HP05-2027DI_Annexure A_Final_5 June 2026.xlsx
The tender (HP05-2027DI) invites bids for the supply and delivery of diagnostic agents and contrast media to the Gauteng Department of Health for a 3-year period (01 July 2027 to 30 June 2030). It mandates strict documentation, compliance with regulatory standards (e.g., SAHPRA, GMP), and adherence to administrative and legal requirements.
8. HP05-2027DI_PBD9.2-Directors-Categorisation-_JV_Consort_P-Ship_5 June 2026.xlsx
The tender HP05-2027DI is for the supply and delivery of diagnostic agents and contrast media to the Gauteng Department of Health for a 3-year period (01 July 2027 to 30 June 2030). It requires multi-entity bidding enterprises to provide detailed information about their structure, directors, and enterprise categorization.
5. HP05-2027DI-Annexure_C_Guidance_QSE_EME_5 June 2026.pdf
The tender (HP05-2027DI) involves the supply and delivery of diagnostic agents and contrast media to the Gauteng Department of Health for a 3-year period (01 July 2027 to 30 June 2030). Bidders must comply with B-BBEE regulations, with specific guidance provided for QSEs (R10M–R50M turnover) and EMEs (<R10M turnover) to claim preference points via a correctly completed sworn affidavit.
7. HP05-2027DI_PBD9.1-Directors-Categorisation-_Single Bid_Entity_5 June 2026.xlsx
The tender HP05-2027DI invites bids for the supply and delivery of diagnostic agents and contrast media to the Gauteng Department of Health for a 3-year period (01 July 2027 to 30 June 2030). The document excerpt (PBD9.1) outlines bidder information requirements, including legal entity details, director information, and business structure classification.
6.HP05-2027DI PBD4.1 Contact Details_Bidder 5 June 2026.xlsx
The tender HP05-2027DI is for the supply and delivery of diagnostic agents and contrast media to the Gauteng Department of Health for a 3-year period (01 July 2027 to 30 June 2030). The closing date for submissions is 03 August 2026.
4. HP05-2027DI_Annexure B_ Invoice requirements_5 June 2026.pdf
The tender HP05-2027DI invites bids for the supply and delivery of diagnostic agents and contrast media to the Gauteng Department of Health for a 3-year period (01 July 2027 to 30 June 2030). It specifies strict invoicing, delivery, and documentation requirements, including detailed data fields for invoices, proof of delivery, and compliance with purchase orders.
1. HP05-2027DI__Invitation to bid_ notice_for NDOH website_5 June 2026.pdf
The tender (HP05-2027DI) invites bids for the supply and delivery of diagnostic agents and contrast media to the Gauteng Department of Health for a 3-year period (01 July 2027 to 30 June 2030). The closing date is 03 August 2026 at 11:00 AM UTC. A non-compulsory online briefing session is scheduled for 19 June 2026 via MS Teams.
2. HP05-2027DI_Final Bid Pack-5 June 2026.pdf
The tender (HP05-2027DI) invites bids for the supply and delivery of diagnostic agents and contrast media to the Gauteng Department of Health for a 3-year period (01 July 2027 to 30 June 2030). It is governed by South African procurement laws, including the Preferential Procurement Policy Framework Act and B-BBEE regulations. Bids close on 03 August 2026 at 11:00 UTC.
To download these documents and access AI-powered analysis, visit the main tender page.
Organization
HealthContact Person
Tenders
Phone
012-395-0000
[email protected]
Website
www.health.gov.za/
Address
1112 Voortrekker Rd, Pretoria Townlands 351-Jr, Pretoria, 0187, South Africa
Source confidence
High source confidence
Official source
eTenders.gov.za
Documents found
9
Last checked
05 Jun 2026
AI status
Enhanced
This tender has strong source evidence, including source metadata and supporting tender information synced from the government tender portal.
Tenders SA is not the issuing authority. All tenders are automatically synced from the official government tender portal. Always confirm final submission details, closing dates, briefing sessions, eligibility requirements, and documents on the official government portal before applying.
The Department of Health leads national health policy and supports provincial health systems across South Africa.
Sets health and safety duties for contractors, employers and service providers working on public-sector sites.
Relevant because this tender appears to involve health services, public health facilities, clinical services, or medical procurement.
Data conflicts
None detected
1112 Voortrekker Rd, Pretoria Townlands 351-Jr, Pretoria, 0187, South Africa
Get deep intelligence on Supplies: Medical. Unlock full pricing strategies, bid frequency, and historical win rates.